肺癌免疫微环境中的肿瘤相关巨噬细胞

摘要/Abstract

摘要：随着对肿瘤免疫发生和免疫耐受认识的不断深入，肺癌免疫治疗成为研究的热点。肿瘤免疫微环境在肺癌的发生、发展、转移过程中起着重要作用。肿瘤相关巨噬细胞（TAM）是肺癌免疫微环境中白细胞的主要成分之一，TAM和肺癌的关系随着研究的深入而逐渐明确，TAM作为肺癌免疫治疗新的靶点成为可能。

丁怡慧, 张锴, 胡悦, 刘莉. 肺癌免疫微环境中的肿瘤相关巨噬细胞[J]. 国际肿瘤学杂志, 2014, 41(11): 830-833.

DING Yi-Hui, ZHANG Kai, HU Yue, LIU Li. Tumor-associated macrophages in immune microenvironment of lung cancer[J]. Journal of International Oncology, 2014, 41(11): 830-833.

［1］ Siegel R, Ma J, Zou Z, et al. Cancer Statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 929. ［2］ Schmieder A, Michel J, Schnhaar K, et al. Differentiation and gene expression profile of tumorassociated macrophages［J］. Semin Cancer Biol， 2012, 22(4):289297. ［3］ Shirabe K, Mano Y, Muto J, et al. Role of tumorassociated macrophages in the progression of hepatocellular carcinoma［J］. Surg Today， 2012, 42(1):17. ［4］ Wang XF, Wang HS, Zhang F, et al. Nodal promotes the generation of M2like macrophages and downregulates the expression of IL12［J］. Eur J Immunol， 2014， 44(1):173183. ［5］ Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment［J］. Trends Immunol, 2012, 33(3):119126. ［6］ Quatromoni JG, Eruslanov E. Tumorassociated macrophages: function, phenotype, and link to prognosis in human lung cancer［J］. Am J Transl Res, 2012, 4(4):376389. ［7］ Dasanu CA, Sethi N, Ahmed N. Immune alterations and emerging immunotherapeutic approaches in lung cancer［J］. Expert Opin Biol Ther， 2012, 12(7):923937. ［8］ Chung FT, Lee KY, Wang CW, et al. Tumorassociated macrophages correlate with response to epidermal growth factor receptortyrosine kinase inhibitors in advanced nonsmall cell lung cancer［J］. Int J Cancer, 2012, 131(3):E227E235. ［9］ Hunder NN, Wallen H, Cao J, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NYESO1［J］. N Engl J Med, 2008, 358(25):26982703. ［10］ Reck M. What future opportunities may immunooncology provide for improving the treatment of patients with lung cancer?［J］. Ann Oncol， 2012，23 Suppl 8:viii2834. ［11］ Brahmer JR. Harnessing the immune system for the treatment of nonsmallcell lung cancer［J］. J Clin Oncol, 2013, 31(8):10211028. ［12］ Shepherd FA, Douillard JY, Blumenschein GR Jr. Immunotherapy for nonsmall cell lung cancer: novel approaches to improve patient outcome［J］. J Thorac Oncol， 2011, 6(10):17631773. ［13］徐燕, 王孟昭. 非小细胞肺癌免疫治疗进展［J］. 中国肺癌杂志, 2014, 17(1): 3441. ［14］ Lievense LA, Bezemer K, Aerts JG, et al. Tumorassociated macrophages in thoracic malignancies［J］. Lung Cancer, 2013, 80(3):256262. ［15］ Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers［J］. J Transl Med， 2011， 9: 216. ［16］ Wang R, Zhang J, Chen S, et al. Tumorassociated macrophages provide a suitable microenvironment for nonsmall lung cancer invasion and progression［J］. Lung Cancer, 2011, 74(2):188196. ［17］ Zhang Y, Choksi S, Chen K, et al. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumorassociated macrophages［J］. Cell Res, 2013, 23(7):898914. ［18］ Zhang Y, Choksi S, Liu ZG. Butylated hydroxyanisole blocks the occurrence of tumor associated macrophages in tobacco smoke carcinogeninduced lung tumorigenesis［J］. Cancers (Basel), 2013， 5(4): 16431654. ［19］ Germano G, Frapolli R, Belgiovine C, et al. Role of macrophage targeting in the antitumor activity of trabectedin［J］. Cancer Cell, 2013, 23(2):249262. ［20］ Welsh TJ, Green RH, Richardson D, et al. Macrophage and mastcell invasion of tumor cell islets confers a marked survival advantage in nonsmallcell lung cancer［J］. J Clin Oncol, 2005, 23(35):89598967. ［21］ Ohri CM, Shikotra A, Green RH, et al. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival［J］. Eur Respir J, 2009, 33(1):118126. ［22］ Shao R. YKL40 acts as an angiogenic factor to promote tumor angiogenesis［J］. Front Physiol, 2013, 4(122):19. ［23］ Thm I, Andritzky B, Schuch G, et al. Elevated pretreatment serum concentration of YKL40An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer［J］. Cancer, 2010, 116(17): 41144121. ［24］ Standiford TJ, Kuick R, Bhan U, et al. TGFβinduced IRAKM expression in tumorassociated macrophages regulates lung tumor growth［J］. Oncogene， 2011, 30(21):24752484. ［25］ Kühnemuth B, Mühlberg L, Schipper M, et al. CUX1 modulates polarization of tumorassociated macrophages by antagonizing NFκB signaling［J］. Oncogene， 2013， In press.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[3]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[4]	贺嘉慧, 胡钦勇.基于GBD数据的中国和美国肺癌发病和死亡趋势及危险因素对比分析[J]. 国际肿瘤学杂志, 2024, 51(1): 29-36.
[5]	贺嘉慧, 胡钦勇.放疗联合特瑞普利单抗和GM-CSF治疗鼻腔鼻窦腺样囊性癌1例并文献复习[J]. 国际肿瘤学杂志, 2023, 50(7): 442-444.
[6]	张丽, 向卓, 王强, 毕经旺.CAR-T免疫治疗相关的细胞因子释放综合征研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 377-381.
[7]	李雄安, 颜艳艳.丙戊酸镁用于治疗继发癫痫的晚期肺癌脑转移患者1例报道[J]. 国际肿瘤学杂志, 2023, 50(3): 191-192.
[8]	廖利华, 王少洪, 陈洪才, 赵勇强.细胞蜡块免疫组织化学与胸腔积液CRKL、MIC-1诊断恶性胸腔积液的价值[J]. 国际肿瘤学杂志, 2023, 50(2): 71-75.
[9]	左小平, 刘晓川, 吴西强, 李周, 夏天, 刘国凤.老年早期肺癌患者经胸腔镜肺切除术后心律失常发生的危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(12): 711-716.
[10]	陈郁, 许华, 刘海, 陈士新.基于CT影像学特征的恶性肺纯磨玻璃结节患者病理分型预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(11): 655-660.
[11]	陶红, 殷红, 罗宏, 陶佳瑜.靶向肿瘤相关巨噬细胞增强结直肠癌免疫检查点抑制剂疗效的潜在策略[J]. 国际肿瘤学杂志, 2023, 50(11): 683-687.
[12]	张万芳, 王尤, 苏晶, 陈刚, 周福祥.肺原发尤文肉瘤/原始神经外胚层瘤1例[J]. 国际肿瘤学杂志, 2023, 50(1): 62-64.
[13]	杨莎, 杨晓华, 王苏华, 薛晓燕, 徐俊.老年肺癌胸腔镜手术后下肢深静脉血栓的危险因素分析及预测模型的建立和验证[J]. 国际肿瘤学杂志, 2022, 49(9): 532-536.
[14]	王津, 张耀圣, 孙婷婷, 王丹, 胡乃东.以前胸壁聚集性多发蕈状肿物为表现的肺腺鳞状细胞癌皮肤转移1例[J]. 国际肿瘤学杂志, 2022, 49(9): 575-576.
[15]	陈煌婧, 朱鹏飞, 张晴, 陈桂芳, 杨春林, 何英.超声造影和CT引导下经皮穿刺活检在周围型肺肿块诊断中临床价值的比较[J]. 国际肿瘤学杂志, 2022, 49(8): 459-463.

肺癌免疫微环境中的肿瘤相关巨噬细胞

Tumor-associated macrophages in immune microenvironment of lung cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价